During the past decade, Pärnu Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pärnu Hospital" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Inovio Pharmaceuticals" with 2 trials sponsored, "Advanz Pharma" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pärnu Hospital" #1 collaborator was "Norwegian Health Association" with 1 trials as a collaborator, "The Royal Norwegian Ministry of Health" with 1 trials as a collaborator and "UiT The Arctic University of Norway" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Pärnu Hospital" are "Arthritis, Rheumatoid" (2 trials), "Cervical Dysplasia" (2 trials), "Cervical High Grade Squamous Intraepithelial Lesion" (2 trials), "HSIL" (2 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Pärnu Hospital" in a lesser frequency.

Most popular intervention types in "Pärnu Hospital" are "Drug" (8 trials), "Biological" (3 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BI 695501" (2 trials), "VGX-3100" (2 trials), "Apremilast 20mg" (1 trials) and "Apremilast 30mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pärnu Hospital" are 8 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Pärnu Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Pärnu Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pärnu Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".